They showed thatbreast cancer cells with wild type P53 are more sensitive in treatment withhypericin[ref: Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared toMDA-MB-231]. This evidence concerns the gene TP53 and cancer.